StonvexLoading…
StonvexStonvexStonvexCore line items from STKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $805.72M | $673.34M | $332.77M | $316.64M |
Operating Income | $8.00M | $8.90M | $9.29M | $16.31M |
Net Income | $-92.24M | $-17.10M | $4.72M | $13.53M |
EPS (Diluted) | $-4.05 | $-1.16 | $0.15 | $0.40 |
Total Assets | $884.20M | $960.08M | $317.25M | $291.02M |
Total Liabilities | $772.72M | $758.75M | $249.88M | $222.43M |
Cash & Equivalents | $4.17M | $27.58M | $21.05M | $55.12M |
Free Cash Flow OCF − CapEx | $-27.28M | $-27.37M | $-22.77M | $-7.38M |
Shares Outstanding | 31.24M | 31.04M | 31.28M | 31.74M |